IMI projects contributed significantly to the development of Ebola vaccines and diagnostic tests.
Site Search
Site Search
Displaying results 11 - 20 of 126
17/05/2022
Vaccine potency drops in the elderly and little is known about why this happens. Now European scientists are on a mission to understand waning immunity and to develop strategies...
Standardization and development of assays for assessment of influenza vaccines correlates of protection
Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II
Zoonotic anticipation and preparedness initiative
12/04/2022
COVID-19 vaccines do not raise the risk of developing four rare neurological disorders, but an increased risk was seen in unvaccinated infected people with the disease.
30/01/2024
The VITAL project analysed and classified people according to their immune system profiles to evaluate their response to influenza vaccination.
10/11/2023 11:00 - 12:30
How do IMI projects facilitate innovations in vaccine development and effectiveness assessment?
Development of Robust and Innovative Vaccine Effectiveness
24/04/2025
The VITAL project published an educational platform as well as a toolbox to boost vaccination uptake amongst older people.